Details for New Drug Application (NDA): 214463
✉ Email this page to a colleague
The generic ingredient in NAPROXEN SODIUM is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.
Summary for 214463
Tradename: | NAPROXEN SODIUM |
Applicant: | Patheon Softgels |
Ingredient: | naproxen sodium |
Patents: | 0 |
Pharmacology for NDA: 214463
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 214463
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 214463 | ANDA | Bayer Healthcare LLC | 0280-0105 | 0280-0105-01 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0280-0105-01) |
NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 214463 | ANDA | Bayer Healthcare LLC | 0280-0105 | 0280-0105-02 | 160 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0280-0105-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | Jan 10, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription